Clientèle Limited (JSE:CLI)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 1,550.00
0.00 (0.00%)
At close: Mar 20, 2026
Clientèle Income Statement
Financials in millions ZAR. Fiscal year is July - June.
Millions ZAR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Premiums & Annuity Revenue | 3,898 | 3,403 | 1,931 | 1,954 | 2,050 | 2,169 |
Total Interest & Dividend Income | -533.15 | -473.37 | -355.23 | -435.66 | 8.09 | 9.73 |
Gain (Loss) on Sale of Investments | 1,247 | 1,133 | 843.6 | 766.73 | 285.28 | 507.1 |
Other Revenue | 448.29 | 407.57 | 379.09 | 344.88 | 221 | 181.17 |
| 5,060 | 4,470 | 2,799 | 2,630 | 2,564 | 2,867 | |
Revenue Growth (YoY) | 33.62% | 59.74% | 6.41% | 2.57% | -10.58% | -8.73% |
Policy Benefits | 3,204 | 2,944 | 1,760 | 1,789 | 322.55 | 533.24 |
Policy Acquisition & Underwriting Costs | - | - | - | - | - | 1,149 |
Selling, General & Administrative | 581.86 | 551.17 | 420.7 | 418.75 | 1,442 | 322.69 |
Provision for Bad Debts | 0.94 | 6.46 | -2.48 | -0.65 | 3.25 | - |
Non-Insurance Activities Expense | 28.02 | 34.44 | 40.54 | 24.85 | 13.22 | 14.88 |
Other Operating Expenses | -2.2 | -2.2 | -2.94 | -1.76 | -1.4 | - |
Reinsurance Income or Expense | - | - | - | - | -6.95 | 52.39 |
Total Operating Expenses | 3,812 | 3,534 | 2,215 | 2,230 | 1,787 | 1,967 |
Operating Income | 1,248 | 936.26 | 583.2 | 399.96 | 777.17 | 900.12 |
Interest Expense | -58.92 | -39.5 | -33.17 | -25.43 | -22.81 | -20.27 |
Other Non Operating Income (Expenses) | -0 | - | - | - | -114.81 | -301.6 |
EBT Excluding Unusual Items | 1,189 | 896.76 | 550.03 | 374.53 | 639.55 | 578.25 |
Gain (Loss) on Sale of Assets | - | - | - | 0.01 | 0.69 | 0.16 |
Other Unusual Items | - | 403.15 | - | - | - | - |
Pretax Income | 1,189 | 1,300 | 550.03 | 374.54 | 640.23 | 578.41 |
Income Tax Expense | 361.59 | 240.56 | 216.12 | 28.13 | 219.88 | 186.15 |
Earnings From Continuing Ops. | 827.07 | 1,059 | 333.91 | 346.41 | 420.35 | 392.26 |
Minority Interest in Earnings | -6.1 | -4.61 | -3.97 | -2.36 | - | - |
Net Income | 820.97 | 1,055 | 329.94 | 344.05 | 420.35 | 392.26 |
Net Income to Common | 820.97 | 1,055 | 329.94 | 344.05 | 420.35 | 392.26 |
Net Income Growth | -5.32% | 219.68% | -4.10% | -18.15% | 7.16% | 19.40% |
Shares Outstanding (Basic) | 453 | 449 | 335 | 335 | 335 | 335 |
Shares Outstanding (Diluted) | 453 | 454 | 336 | 336 | 336 | 336 |
Shares Change (YoY) | 14.47% | 35.24% | 0.02% | -0.01% | 0.01% | 0.02% |
EPS (Basic) | 1.81 | 2.35 | 0.98 | 1.03 | 1.25 | 1.17 |
EPS (Diluted) | 1.81 | 2.32 | 0.98 | 1.02 | 1.25 | 1.17 |
EPS Growth | -17.29% | 136.37% | -4.12% | -18.15% | 7.14% | 19.40% |
Free Cash Flow | 965.47 | 914.56 | 429.3 | 174.09 | 469.51 | 339.86 |
Free Cash Flow Per Share | 2.13 | 2.01 | 1.28 | 0.52 | 1.40 | 1.01 |
Dividend Per Share | 1.320 | 1.320 | 1.250 | 1.250 | 1.200 | 1.100 |
Dividend Growth | 5.60% | 5.60% | - | 4.17% | 9.09% | 15.79% |
Operating Margin | 24.66% | 20.94% | 20.84% | 15.21% | 30.31% | 31.39% |
Profit Margin | 16.23% | 23.59% | 11.79% | 13.08% | 16.39% | 13.68% |
Free Cash Flow Margin | 19.08% | 20.46% | 15.34% | 6.62% | 18.31% | 11.85% |
EBITDA | 1,315 | 963.4 | 596.78 | 413.02 | 790.73 | 914.93 |
EBITDA Margin | 25.99% | 21.55% | 21.32% | 15.70% | 30.84% | 31.91% |
D&A For EBITDA | 67.48 | 27.14 | 13.58 | 13.06 | 13.55 | 14.81 |
EBIT | 1,248 | 936.26 | 583.2 | 399.96 | 777.17 | 900.12 |
EBIT Margin | 24.66% | 20.94% | 20.84% | 15.21% | 30.31% | 31.39% |
Effective Tax Rate | 30.42% | 18.51% | 39.29% | 7.51% | 34.34% | 32.18% |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.